Previous 10 | Next 10 |
The following slide deck was published by Vericel Corporation in conjunction with this event. For further details see: Vericel (VCEL) Presents At H.C. Wainwright Global Life Sciences 2021 Virtual Conference - Slideshow
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the Oppenheimer 31...
CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Joe Mara, Chief Financial Officer, will present the latest company overview at the H.C. Wainwrigh...
Image source: The Motley Fool. Vericel (NASDAQ: VCEL) Q4 2020 Earnings Call Feb 24, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Vericel (VCEL) Q4 2020 Earnings Call Transcript
Vericel Corporation (VCEL) Q4 2020 Earnings Conference Call February 24, 2021 8:30 AM ET Company Participants Eric Burns - Head of Financial Planning & Analysis & Investor Relations Nick Colangelo - President & Chief Executive Officer Joe Mara - Chief Financial Officer Conference ...
The following slide deck was published by Vericel Corporation in conjunction with their 2020 Q4 earnings call. For further details see: Vericel Corporation 2020 Q4 - Results - Earnings Call Presentation
Vericel (VCEL): Q4 GAAP EPS of $0.25 beats by $0.05.Revenue of $45.2M (+14.7% Y/Y) beats by $0.2M.Press Release For further details see: Vericel EPS beats by $0.05, beats on revenue
Record Fourth Quarter Total Revenue, Gross Margin, Net Income and Operating Cash Flow Full-Year 2021 Total Revenue Expected to Grow 30%-32% to Approximately $161 to $164 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEW...
[[AVA]], [[BHC]], [[CLH]], [[CQP]], [[CSPR]], [[DEA]], [[ELAN]], [[ENBL]], [[ETR]], [[EV]], [[EXC]], [[FDP]], [[GCP]], [[HFC]], [[HZNP]], [[IBP]], [[IONS]], [[IRM]], [[ITRI]], [[KOP]], [[LIVN]], [[LNG]], [[LOW]], [[NEO]], [[ODP]], [[OMI]], [[OSTK]], [[PGTI]], [[PLAB]], [[PNW]], [[PSN]], [[RGE...
Vericel (NASDAQ:VCEL) is scheduled to announce Q4 earnings results on Wednesday, February 24th, before market open.The consensus EPS Estimate is $0.20 (flat Y/Y) and the consensus Revenue Estimate is $45M (+14.2% Y/Y).Over the last 2 years, VCEL has beaten EPS estimates 75% of the time and ha...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Karen Mahoney as Chief Human Resources Officer following the retirement of Heidi Hassen, w...
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2024 financial results on Thursday, August 1, 2024. Vericel’s m...
2024-07-08 00:00:04 ET Ryan Zimmerman from BTIG issued a price target of $56.00 for VCEL on 2024-07-05 10:09:00. The adjusted price target was set to $56.00. At the time of the announcement, VCEL was trading at $46.68. The overall price target consensus is at $48.00 with...